Last reviewed · How we verify
Moderna mRNA-1273.222
Moderna mRNA-1273.222 is a Biologic drug developed by COVID-19 Prevention Network. It is currently in Phase 2 development.
At a glance
| Generic name | Moderna mRNA-1273.222 |
|---|---|
| Sponsor | COVID-19 Prevention Network |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern (PHASE2, PHASE3)
- A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (PHASE2, PHASE3)
- A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (PHASE3)
- Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines (PHASE1, PHASE2)
- A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants (PHASE2, PHASE3)
- An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Moderna mRNA-1273.222 CI brief — competitive landscape report
- Moderna mRNA-1273.222 updates RSS · CI watch RSS
- COVID-19 Prevention Network portfolio CI
Frequently asked questions about Moderna mRNA-1273.222
What is Moderna mRNA-1273.222?
Moderna mRNA-1273.222 is a Biologic drug developed by COVID-19 Prevention Network.
Who makes Moderna mRNA-1273.222?
Moderna mRNA-1273.222 is developed by COVID-19 Prevention Network (see full COVID-19 Prevention Network pipeline at /company/covid-19-prevention-network).
What development phase is Moderna mRNA-1273.222 in?
Moderna mRNA-1273.222 is in Phase 2.
Related
- Manufacturer: COVID-19 Prevention Network — full pipeline